Skip to content
Adrienne Monson – Lifestyle
Author:
Calico Life Sciences LLC
Calico Life Sciences Announces European Medicines Agency Grants PRIME Designation to Investigational Fosigotifator for Vanishing White Matter
October 22, 2026
Calico Life Sciences Announces Fosigotifator Granted Breakthrough Therapy Designation by the U.S. FDA for the Treatment of Vanishing White Matter Disease
June 23, 2026